Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Data on blood pressure (BP) in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency are conflicting in the literature. PATIENTS AND METHODS: BP data of n = 716 children and adolescents (aged 3-18 years) from a national CAH database were analyzed. BP data were adjusted for height and compared to contemporary national reference data. A systolic and diastolic BP above the 95th centile was defined as hypertensive. RESULTS: Overall prevalence of hypertension was 12.5%. Prevalence of hypertension was higher in younger children than in adolescents (18.5% vs. 4.9%). Until 8 years of age, fludrocortisone dose/m(2)/day correlated significantly with BP in regression analysis (P < 0.0001). BP correlated significantly with body mass index standard deviation score (BMI-SDS) (P < 0.0001), but not with hydrocortisone dose. In patients with salt-wasting CAH, BMI-SDS and BP were significantly higher compared to patients with simple virilising CAH, P < 0.01. CONCLUSION: Especially young CAH children seem to be at risk for-most likely transient-hypertension, since the prevalence of hypertension decreases with age. In children up to 8 years of age, the used fludrocortisone dose is a significant risk factor for hypertension. Therefore we recommend accurate measurement of BP and careful fludrocortisone dosing in children with CAH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a large cohort of patients with CAH (n = 716, aged 3–18 years) in Germany, the prevalence of hypertension was 12.5% and it was more commonly observed in younger children (aged <18 months) than in adolescents (18.5% versus 4.9%).”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [43]
In the citing paper
“Fludrocortisone dose was a risk factor for hypertension in children aged <8 years43.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [43]
In the citing paper
“In a population-based study of children (n = 716; age range, 3 to 18 years), the dose of fludrocortisone was associated with blood pressure, and children with regularly measured PRA had lower blood pressure than did those without PRA documentation (217).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [217]
Citations
Cites
Kromeyer-Hauschild, K., Wabitsch, M., Kunze, D., Geller, F., Geiß, H. C., Hesse, V., von Hippel, A., Jaeger, U., Johnsen, D., Korte, W., et al. (2001) · Monatsschrift Kinderheilkunde · doi:10.1007/s001120170107 · Cited by 2,175
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Blood Pressure Percentiles by Age and Height From Nonoverweight Children and Adolescents in Germany
Neuhauser, H. K., Thamm, M., Ellert, U., Hense, H. W., & Rosario, A. S. (2011) · Pediatrics · doi:10.1542/peds.2010-1290 · Cited by 281
Congenital adrenal hyperplasia—a continuum of disorders
Hughes, I. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)22037-x · Cited by 141
Roche, E. F., Charmandari, E., Dattani, M. T., & Hindmarsh, P. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01757.x · Cited by 113
Völkl, T. M. K., Simm, D., Dötsch, J., Rascher, W., & Dörr, H. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1069 · Cited by 91
Self-citationSubbarayan, A., Dattani, M. T., Peters, C. J., & Hindmarsh, P. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12265 · Cited by 73
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Caring for individuals with a difference of sex development (DSD): a Consensus Statement
Cools, M., Nordenström, A., Robeva, R., Hall, J., Westerveld, P., Flück, C., Köhler, B., Berra, M., Springer, A., Schweizer, K., et al. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0010-8 · Cited by 461
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Tamhane, S., Rodriguez-Gutierrez, R., Iqbal, A. M., Prokop, L. J., Bancos, I., Speiser, P. W., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01862 · Cited by 123
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Metadata
- Authors
- Bonfig, W., Roehl, F.-W., Riedl, S., Dörr, H. G., Bettendorf, M., Brämswig, J., Schönau, E., Riepe, F., Hauffa, B., Holl, R. W., Mohnike, K., & The AQUAPE CAH Study Group
- Affiliations
- Technical University of Munich (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University of Vienna (AT)
- Universitätsklinikum Erlangen (DE)
- University Hospital Heidelberg (DE)
- University Hospital Münster (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Essen University Hospital (DE)
- Universität Ulm (DE)
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-11
- Volume
- 29
- Issue
- 2
- Pages
- 266-272
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W2439202089
- Cited by
- 84
- References
- 16
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 28 · 2023: 6 · 2022: 10 · 2021: 2 · 2020: 3 · 2019: 8 · 2018: 12 · 2017: 2 · 2016: 1
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- classic congenital adrenal hyperplasia, 21-hydroxylase deficiency, hypertension prevalence, blood pressure, children and adolescents, salt-wasting CAH, body mass index, hydrocortisone dose, transient hypertension
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Blood Pressure, Child, Child, Preschool, Female, Humans, Male, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. https://app.cochat.ai/papers/10.1093/ajh/hpv087
- The paper
- Bonfig, W., Roehl, F.-W., Riedl, S., Dörr, H. G., Bettendorf, M., Brämswig, J., Schönau, E., Riepe, F., Hauffa, B., Holl, R. W., Mohnike, K., & The AQUAPE CAH Study Group. (2016). Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpv087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.